原発性不眠症でも 同様の効果はあるのか? ベイジアンネットワークのメタ解析
Yuting Wang1, Minmin Wu2, Jiongliang Zhang1
1Second Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, People's Republic of China.
Nature and science of sleep
|September 5, 2025
まとめ
主要不眠症 (PI) の成人の場合,治療 (AT) は偽治療と比較して主観的な睡眠の質を著しく改善します. 非侵襲的偽針治療 (NISA) は,将来の試験の対照として推奨されます.
科学分野:
- 統合医療
- 睡眠科学
- 証拠 に 基づく 実践
背景:
- 主要不眠症 (PI) は,成人の生活の質に影響を与える一般的な睡眠障害です.
- 治療 (AT) はPIの潜在的な治療法ですが,偽の対照と比較してその有効性は厳格な評価を必要とします.
- 様々な偽アキュプンクチャーの効果を理解することは 確固たる臨床試験の設計に不可欠です
研究 の 目的:
- 成人における原発性不眠症 (PI) の治療における治療 (AT) と偽治療の有効性を比較する.
- 治療結果に対する様々な偽薬 (非侵襲的偽薬 - NISA,表面的偽薬 - SA) の影響を分析する.
- PI 治療の研究における対照群の選択のための証拠に基づいた勧告を提供すること.
主な方法:
- 3004人の参加者を含む33件のランダム化対照試験 (RCT) のベイジアンネットワークメタ解析.
- 2025年4月23日までの7つのデータベースの文献検索
- R (バージョン4.4.1) とStata (バージョン15.1) を用いた統計分析
主要な成果:
- 治療の終点と4週間で,表面的治療 (SA) と非侵襲的偽治療 (NISA) と比較して,治療 (AT) は主観的な睡眠品質 (ピッツバーグ睡眠品質指数 - PSQI) を有意に改善しました.
- ATは,臨床的に重要な最小差 (MCID) を上回る,臨床的に有意義な改善を示した.
- 客観的な睡眠パラメータに関して,AT,NISA,およびSAの間で有意な差は認められず,SA,NISA,および非治療 (NAT) の間の差は有意ではなかった.
結論:
- 治療 (AT) は,原発性不眠症 (PI) の患者の主観的な睡眠の質を向上させるのに有効です.
- 非侵襲的偽針治療 (NISA) は,PIのための治療を調査する将来のRCTの適切な偽針治療として推奨されます.
- 将来の研究は客観的な睡眠測定を優先し,一般化性を高めるために国際的多センター試験を組み込むべきです.
関連する概念動画
01:19Management of Insomnia
319
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
319
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
236
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
236
02:07Blind Procedures
12.1K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.1K
01:23Sedatives and Hypnotics: Overview
629
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
629
01:27Insomnia
123
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
123
01:14CNS Depressants: Barbiturates and Benzodiazepines
462
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
462